Matches in SemOpenAlex for { <https://semopenalex.org/work/W4245859688> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W4245859688 endingPage "530" @default.
- W4245859688 startingPage "507" @default.
- W4245859688 abstract "Since the discovery of an endogenous cannabinoid system, research into the pharmacology and therapeutic potential of cannabinoids has steadily increased. Two subtypes of G-protein coupled cannabinoid receptors, CB1 and CB2, have been cloned and several putative endogenous ligands (endocannabinoids) have been detected during the past 15 years. The main endocannabinoids are arachidonoyl ethanolamide (anandamide) and 2-arachidonoyl glycerol (2-AG), derivatives of arachidonic acid, that are produced on demand by cleavage of membrane lipid precursors. Besides phytocannabinoids of the cannabis plant, modulators of the cannabinoid system comprise synthetic agonists and antagonists at the CB receptors and inhibitors of endocannabinoid degradation. Cannabinoid receptors are distributed in the central nervous system and many peripheral tissues, including immune system, reproductive and gastrointestinal tracts, sympathetic ganglia, endocrine glands, arteries, lung and heart. There is evidence for some non-receptor dependent mechanisms of cannabinoids and for endocannabinoid effects mediated by vanilloid receptors. Properties of CB receptor agonists that are of therapeutic interest include analgesia, muscle relaxation, immunosuppression, anti-inflammation, antiallergic effects, improvement of mood, stimulation of appetite, antiemesis, lowering of intraocular pressure, bronchodilation, neuroprotection and antineoplastic effects. The current main focus of clinical research is their efficacy in chronic pain and neurological disorders. CB receptor antagonists are under investigation for medical use in obesity and nicotine addiction. Additional potential was proposed for the treatment of alcohol and heroine dependency, schizophrenia, conditions with lowered blood pressure, Parkinsons disease and memory impairment in Alzheimers disease. Keywords: cannabis, thc, cannabinoids, cannabinoid receptors, endocannabinoids, cannabinoid receptor antagonists, therapeutic potential, side effects" @default.
- W4245859688 created "2022-05-12" @default.
- W4245859688 creator A5030440080 @default.
- W4245859688 date "2005-10-01" @default.
- W4245859688 modified "2023-10-04" @default.
- W4245859688 title "Cannabinoids" @default.
- W4245859688 doi "https://doi.org/10.2174/156800705774322111" @default.
- W4245859688 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16266285" @default.
- W4245859688 hasPublicationYear "2005" @default.
- W4245859688 type Work @default.
- W4245859688 citedByCount "88" @default.
- W4245859688 countsByYear W42458596882012 @default.
- W4245859688 countsByYear W42458596882013 @default.
- W4245859688 countsByYear W42458596882014 @default.
- W4245859688 countsByYear W42458596882015 @default.
- W4245859688 countsByYear W42458596882016 @default.
- W4245859688 countsByYear W42458596882017 @default.
- W4245859688 countsByYear W42458596882018 @default.
- W4245859688 countsByYear W42458596882019 @default.
- W4245859688 countsByYear W42458596882020 @default.
- W4245859688 countsByYear W42458596882021 @default.
- W4245859688 countsByYear W42458596882022 @default.
- W4245859688 countsByYear W42458596882023 @default.
- W4245859688 crossrefType "journal-article" @default.
- W4245859688 hasAuthorship W4245859688A5030440080 @default.
- W4245859688 hasConcept C126322002 @default.
- W4245859688 hasConcept C148001335 @default.
- W4245859688 hasConcept C155164980 @default.
- W4245859688 hasConcept C160145004 @default.
- W4245859688 hasConcept C170493617 @default.
- W4245859688 hasConcept C25498285 @default.
- W4245859688 hasConcept C2778938600 @default.
- W4245859688 hasConcept C2780871563 @default.
- W4245859688 hasConcept C2910065304 @default.
- W4245859688 hasConcept C46721173 @default.
- W4245859688 hasConcept C61372379 @default.
- W4245859688 hasConcept C71924100 @default.
- W4245859688 hasConcept C93248783 @default.
- W4245859688 hasConcept C98274493 @default.
- W4245859688 hasConceptScore W4245859688C126322002 @default.
- W4245859688 hasConceptScore W4245859688C148001335 @default.
- W4245859688 hasConceptScore W4245859688C155164980 @default.
- W4245859688 hasConceptScore W4245859688C160145004 @default.
- W4245859688 hasConceptScore W4245859688C170493617 @default.
- W4245859688 hasConceptScore W4245859688C25498285 @default.
- W4245859688 hasConceptScore W4245859688C2778938600 @default.
- W4245859688 hasConceptScore W4245859688C2780871563 @default.
- W4245859688 hasConceptScore W4245859688C2910065304 @default.
- W4245859688 hasConceptScore W4245859688C46721173 @default.
- W4245859688 hasConceptScore W4245859688C61372379 @default.
- W4245859688 hasConceptScore W4245859688C71924100 @default.
- W4245859688 hasConceptScore W4245859688C93248783 @default.
- W4245859688 hasConceptScore W4245859688C98274493 @default.
- W4245859688 hasIssue "5" @default.
- W4245859688 hasLocation W42458596881 @default.
- W4245859688 hasLocation W42458596882 @default.
- W4245859688 hasOpenAccess W4245859688 @default.
- W4245859688 hasPrimaryLocation W42458596881 @default.
- W4245859688 hasRelatedWork W1522906413 @default.
- W4245859688 hasRelatedWork W185450831 @default.
- W4245859688 hasRelatedWork W1982186440 @default.
- W4245859688 hasRelatedWork W2015829020 @default.
- W4245859688 hasRelatedWork W2031649661 @default.
- W4245859688 hasRelatedWork W2088083175 @default.
- W4245859688 hasRelatedWork W2088908088 @default.
- W4245859688 hasRelatedWork W2133559511 @default.
- W4245859688 hasRelatedWork W3033469112 @default.
- W4245859688 hasRelatedWork W3206032565 @default.
- W4245859688 hasVolume "4" @default.
- W4245859688 isParatext "false" @default.
- W4245859688 isRetracted "false" @default.
- W4245859688 workType "article" @default.